Skopos Labs, Inc. Adaptive Biotechnologies Corp Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Skopos Labs, Inc. holds 2,720 shares of ADPT stock, worth $25,976. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,720
Previous 2,989
9.0%
Holding current value
$25,976
Previous $17,000
17.65%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ADPT
# of Institutions
246Shares Held
156MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$286 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$125 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$111 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$106 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.73MShares$73.8 Million0.62% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.36B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...